Ocugen, Inc. - Common Stock (NQ:OCGN)

1.040 +0.020 (+1.96%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

36 37 Next >

Ocugen Appoints Quan A. Vu as Chief Business Officer

February 01, 2023

From Ocugen

Via GlobeNewswire

Ocugen, Inc. to Present at 2023 BIO CEO & Investor Conference

January 31, 2023

From Ocugen

Via GlobeNewswire

2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague ↗

January 29, 2023

Two of these stocks have what it takes to rebound and deliver lasting gains.

Via The Motley Fool

Why GeneDx Holdings Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket ↗

January 27, 2023

Gainers Freightos Limited (NASDAQ: CRGO) shares rose 69.2% to $17.75 in pre-market trading. Freightos listed on the Nasdaq following merger with special purpose acquisition company, Gesher I...

Via Benzinga

Ocugen Announces Encouraging Data From Late-Stage COVID-19 Vaccine Study ↗

January 09, 2023

Via Benzinga

Why Shares of Ocugen Jumped Thursday ↗

December 29, 2022

Could short-sellers be enacting a squeeze?

Via The Motley Fool

3 of the Fastest-Growing Stocks on the Planet in 2023 ↗

January 26, 2023

These hypergrowth stocks are expected to deliver up to 1,075% sales growth this year.

Via The Motley Fool

3 Under-the-Radar Stocks With 590% to 772% Upside in 2023, According to Wall Street ↗

January 23, 2023

Select analysts expect these small-caps stocks to catapult higher in the new year.

Via The Motley Fool

7 ‘Loser’ Stocks to Short for Big Profits ↗

January 11, 2023

These stocks to short can generate significant profits for investors, as they are all tremendously overvalued at this point.

Via InvestorPlace

Exclusive: Top 10 Most Searched Tickers On Benzinga Pro In 2022 — Where Do SPY, Tesla, Apple And AMC Rank? ↗

January 09, 2023

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a leading source for traders to see the latest news on the overall market and individual tickers all in one...

Via Benzinga

Why Ocugen Stock Wilted on Wednesday ↗

November 09, 2022

A prognosticator got less bullish on the company's prospects, and investors took this to heart.

Via The Motley Fool

Ocugen, Inc. (OCGN) Q3 2022 Earnings Call Transcript ↗

November 08, 2022

OCGN earnings call for the period ending September 30, 2022.

Via The Motley Fool

Why Is Party City (PRTY) Stock Up 41% Today? ↗

January 09, 2023

Party City (PRTY) stock is in the news Monday as investors prepare for the celebration goods company to file for bankruptcy.

Via InvestorPlace

Why Is Ocugen (OCGN) Stock Up Today? ↗

January 09, 2023

Ocugen is hoping its Indian-made inactivated Covid-19 shot can provide a low-cost boost for those previously given MRNA-based vaccines.

Via InvestorPlace

Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories ↗

January 09, 2023

Bloomberg

Via Benzinga

Ocugen Announces Positive Top-Line Data for COVID-19 Vaccine Candidate COVAXIN™ (BBV152) in Phase 2/3 Immuno-bridging and Broadening Study: Both Co-primary Endpoints Met

January 09, 2023

From Ocugen

Via GlobeNewswire

7 Hot Meme Stocks of 2022 to Sell Before 2023 ↗

December 25, 2022

The value of most of the meme stocks have plunged, but there are still many meme stocks to sell at this point.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Tuesday ↗

December 20, 2022

On Tuesday, 298 companies achieved new lows for the year.

Via Benzinga

Why Is Agrify (AGFY) Stock Down 50% Today? ↗

December 16, 2022

Agrify (AGFY) stock is on the move Friday as the company's shares take a beating after revealing details of a stock offering.

Via InvestorPlace

OCGN Stock Alert: What to Know About Ocugen’s Latest Phase 3 Clinical Trial ↗

December 16, 2022

OCGN stock fell into the red despite Ocugen's success in advancing a regenerative cell therapy product evaluation.

Via InvestorPlace

Ocugen Announces Phase 3 Confirmatory Clinical Trial Agreement for NeoCart®

December 16, 2022

Important next step for Ocugen’s regenerative cell therapy in orthopedics since announcing pipeline expansion in May 2022

From Ocugen

Via GlobeNewswire

Ocugen, Inc. to Ring the Nasdaq Stock Market Closing Bell

December 13, 2022

From Ocugen

Via GlobeNewswire

7 Tech Stocks to Sell Before They Topple in 2023 ↗

December 08, 2022

It's much harder now than in 2021 to find tech stocks to sell, but some tech names are still dramatically overvalued.

Via InvestorPlace

Ocugen Announces Update on OCU400 Phase 1/2 Clinical Trial Targeting Retinitis Pigmentosa and Leber Congenital Amaurosis

December 07, 2022

From Ocugen

Via GlobeNewswire

Ocugen to Present at 3rd Annual Dry AMD Therapeutics Summit

November 28, 2022

From Ocugen

Via GlobeNewswire

3 Stocks to Avoid Right Now ↗

November 17, 2022

Even though many stocks have fallen sharply in price, not all are bargains -- investors must remains selective.

Via The Motley Fool

Why Ocugen Stock Popped by 7% on Tuesday ↗

November 08, 2022

A third-quarter report, complete with clinical updates, is more than enough to satisfy the biotech's bulls.

Via The Motley Fool

SolarEdge Technologies, LivePerson, TaskUs And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 08, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Ocugen Provides Business Update & Third Quarter 2022 Financial Results

November 08, 2022

From Ocugen

Via GlobeNewswire

Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket ↗

November 08, 2022

Gainers

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

36 37 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.